艾尔建-话题@MedSci - 梅斯（MedSci）

#艾尔建#

7篇内容 | 941人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2070002, encodeId=ebf620e000289, content=<a href='/topic/show?id=d75286e6329' target=_blank style='color:#2F92EE;'>#艾尔建#</a>, objectTitle=艾伯维已完成对艾尔建的全部收购，强大的在研产品组合助力长期可持续增长, objectType=article, longId=193847, objectId=4fb819384e69, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4fb819384e69, replyNumber=0, likeNumber=79, createdTime=2021-03-15, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4fb819384e69, moduleTitle=艾伯维已完成对艾尔建的全部收购，强大的在研产品组合助力长期可持续增长, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4fb819384e69)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2070001, encodeId=059520e0001c3, content=<a href='/topic/show?id=d75286e6329' target=_blank style='color:#2F92EE;'>#艾尔建#</a>, objectTitle=丰胸致癌——FDA要求艾尔建全球召回其乳房植入物, objectType=article, longId=176336, objectId=749b1e6336e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=749b1e6336e0, replyNumber=0, likeNumber=84, createdTime=2020-03-01, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=749b1e6336e0, moduleTitle=丰胸致癌——FDA要求艾尔建全球召回其乳房植入物, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=749b1e6336e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2070000, encodeId=56e920e00004d, content=<a href='/topic/show?id=d75286e6329' target=_blank style='color:#2F92EE;'>#艾尔建#</a>, objectTitle=重磅突发！艾伯维630亿美元收购艾尔建, objectType=article, longId=172195, objectId=b48a1e21957d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b48a1e21957d, replyNumber=0, likeNumber=101, createdTime=2020-06-05, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b48a1e21957d, moduleTitle=重磅突发！艾伯维630亿美元收购艾尔建, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b48a1e21957d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2069998, encodeId=9aaf2069998be, content=<a href='/topic/show?id=d75286e6329' target=_blank style='color:#2F92EE;'>#艾尔建#</a>, objectTitle=FDA批准艾尔建sarecycline治疗9岁以上中重度痤疮, objectType=article, longId=150494, objectId=5c1e150494bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c1e150494bc, replyNumber=0, likeNumber=78, createdTime=2018-11-03, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c1e150494bc, moduleTitle=FDA批准艾尔建sarecycline治疗9岁以上中重度痤疮, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=5c1e150494bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2069999, encodeId=7c7720699992a, content=<a href='/topic/show?id=d75286e6329' target=_blank style='color:#2F92EE;'>#艾尔建#</a>, objectTitle=艾尔建全球首家创新中心在成都正式奠基, objectType=article, longId=157072, objectId=a28515e07241, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a28515e07241, replyNumber=0, likeNumber=79, createdTime=2019-06-09, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a28515e07241, moduleTitle=艾尔建全球首家创新中心在成都正式奠基, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a28515e07241)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2069997, encodeId=5853206999ef6, content=<a href='/topic/show?id=d75286e6329' target=_blank style='color:#2F92EE;'>#艾尔建#</a>, objectTitle=艾尔建美容针BOTOX竟然也成神药啦？治疗抑郁也是棒棒的, objectType=article, longId=86159, objectId=ec1f86159a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec1f86159a2, replyNumber=0, likeNumber=93, createdTime=2017-07-15, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec1f86159a2, moduleTitle=艾尔建美容针BOTOX竟然也成神药啦？治疗抑郁也是棒棒的, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ec1f86159a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2069996, encodeId=8ff62069996b2, content=<a href='/topic/show?id=d75286e6329' target=_blank style='color:#2F92EE;'>#艾尔建#</a>, objectTitle=又一个仿制药！安进/艾尔建公布赫赛汀仿制药III期临床积极数据, objectType=article, longId=73839, objectId=0b9ee38391d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b9ee38391d, replyNumber=0, likeNumber=83, createdTime=2016-11-04, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b9ee38391d, moduleTitle=又一个仿制药！安进/艾尔建公布赫赛汀仿制药III期临床积极数据, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0b9ee38391d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

艾尔建

2020-05-29

yaanren (审核中...)

前往app查看评论内容

#艾尔建#

艾伯维已完成对艾尔建的全部收购，强大的在研产品组合助力长期可持续增长

2021-03-15

yaanren (审核中...)

前往app查看评论内容

#艾尔建#

丰胸致癌——FDA要求艾尔建全球召回其乳房植入物

2020-03-01

yaanren (审核中...)

前往app查看评论内容

#艾尔建#

重磅突发！艾伯维630亿美元收购艾尔建

2020-06-05

yaanren (审核中...)

前往app查看评论内容

#艾尔建#

FDA批准艾尔建sarecycline治疗9岁以上中重度痤疮

2018-11-03

yaanren (审核中...)

前往app查看评论内容

#艾尔建#

艾尔建全球首家创新中心在成都正式奠基

2019-06-09

yaanren (审核中...)

前往app查看评论内容

#艾尔建#

艾尔建美容针BOTOX竟然也成神药啦？治疗抑郁也是棒棒的

2017-07-15

yaanren (审核中...)

前往app查看评论内容

#艾尔建#

又一个仿制药！安进/艾尔建公布赫赛汀仿制药III期临床积极数据

2016-11-04

科室
- - 订阅+
  - 更多科室
工具
服务